| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |